As of August 2026, AMI Labs has a hard baseline of roughly $1.03B, stemming entirely from its record-breaking seed round announced in March 2026 2 sources. There are no publicly reported follow-on rounds, extensions, or compute-debt facilities to date.

The key driver constraining the median forecast is AMI’s explicit strategic divergence from frontier LLM labs. Founder Yann LeCun is deliberately avoiding the brute-force pretraining arms race, arguing that world models (like JEPA) are fundamentally more capital-efficient trendingtopics.eu. A related forecast projects that a more compute-intensive peer lab could reach $22B in median cumulative funding , underscoring how AMI's deliberate non-LLM, capital-efficient strategy substantially limits its expected scale. Set against related questions modeling the lab's valuation and scale, a median outcome of $3.0B better reflects a high probability that AMI relies on its massive seed round without raising a mega-round in 2028.

The lower tail (p10 and p25 of $1.03B) reflects a substantial probability that AMI relies entirely on its existing seed capital through 2028. A billion-dollar war chest provides substantial runway for a lean research team. If AI funding cools, AMI could easily close 2028 without reporting another countable priced equity round.

Conversely, the upper tail (p75 of $8.5B and p90 of $18.0B) accounts for the possibility that non-LLM world models become the industry's primary narrative. If AMI's research yields a credible breakthrough, the lab could command massive sovereign wealth backing and compute-debt financing, pushing cumulative funding well into the tens of billions.